Kestra Private Wealth Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Kestra Private Wealth Services's XBI Position: Q1 2026 in Review
Kestra Private Wealth Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q1 2026, selling an estimated $56.3K and leaving 3,077 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.
Kestra Private Wealth Services first reported a position in XBI in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.85M in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Kestra Private Wealth Services held 3,077 shares of State Street SPDR S&P Biotech ETF worth $393K as of Q1 2026.
- Kestra Private Wealth Services sold 451 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $56.3K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #1320 holding.
- Kestra Private Wealth Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 23 quarters since.
- Kestra Private Wealth Services's State Street SPDR S&P Biotech ETF position peaked at $1.85M in Q1 2024.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.